BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11052822)

  • 1. A comparison of biodistribution of liposomal and soluble IL-2 by a new method based on time-resolved fluorometry of europium.
    Neville ME; Richau KW; Boni LT; Pflug LE; Robb RJ; Popescu MC
    Cytokine; 2000 Nov; 12(11):1702-11. PubMed ID: 11052822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome biodistribution via europium complexes.
    Mignet N; Scherman D
    Methods Mol Biol; 2010; 606():509-18. PubMed ID: 20013418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutics of liposomal interleukin 2, oncolipin.
    Neville ME; Boni LT; Pflug LE; Popescu MC; Robb RJ
    Cytokine; 2000 Nov; 12(11):1691-701. PubMed ID: 11052821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified cytotoxic T lymphocyte precursor frequency assay by measuring released europium in a time resolved fluorometer.
    Haque K; Truman C; Dittmer I; Laundy G; Denning-Kendall P; Hows J; Feest T; Bradley B
    Arch Immunol Ther Exp (Warsz); 1997; 45(1):37-42. PubMed ID: 9090438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Time-resolved fluorometry: principles and applications in clinical biology].
    Gaillard O; Kapel N; Galli J; Delattre J; Meillet D
    Ann Biol Clin (Paris); 1994; 52(11):751-5. PubMed ID: 7747882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome biodistribution by time resolved fluorimetry of lipophilic europium complexes.
    Mignet N; Chermont Qle M; Randrianarivelo T; Seguin J; Richard C; Bessodes M; Scherman D
    Eur Biophys J; 2006 Jan; 35(2):155-61. PubMed ID: 16160824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine.
    Arulsudar N; Subramanian N; Mishra P; Sharma RK; Murthy RS
    J Drug Target; 2003 Apr; 11(3):187-96. PubMed ID: 13129826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome Biodistribution via Europium Complexes.
    Mignet N; Scherman D
    Methods Mol Biol; 2017; 1522():145-154. PubMed ID: 27837537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome Biodistribution via Europium Complexes.
    Mignet N; Scherman D
    Methods Mol Biol; 2023; 2622():277-287. PubMed ID: 36781770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.
    Wilson KD; Raney SG; Sekirov L; Chikh G; deJong SD; Cullis PR; Tam YK
    Int Immunopharmacol; 2007 Aug; 7(8):1064-75. PubMed ID: 17570323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2.
    Neville ME; Robb RJ; Popescu MC
    Cytokine; 2001 Dec; 16(6):239-50. PubMed ID: 11884028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid phase IL-2-IL-2R alpha assay with time resolved fluorometry.
    Stenroos K; Hurskainen P; Blomberg K; Lindqvist C
    Immunol Lett; 1997 Jun; 58(1):15-8. PubMed ID: 9436463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of oligochitosan-tobacco cell interaction by fluorometric method using europium complexes as fluorescence probes.
    Guo W; Ye Z; Wang G; Zhao X; Yuan J; Du Y
    Talanta; 2009 May; 78(3):977-82. PubMed ID: 19269460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for measuring blood-brain barrier permeability demonstrated with Europium-bound albumin during experimental lipopolysaccharide (LPS) induced meningitis in the rat.
    Ivey NS; Martin EN; Scheld WM; Nathan BR
    J Neurosci Methods; 2005 Mar; 142(1):91-5. PubMed ID: 15652621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary examination of time-resolved fluorometry for protein array applications.
    Luo LY; Diamandis EP
    Luminescence; 2000; 15(6):409-13. PubMed ID: 11114118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.